Advertisement
Screener

Lite Strategy, Inc. (LITS) Proceeds from Issuance of Private Placement

2.2 / 5 stars · 45/104 Roast Me

Lite Strategy, Inc. Proceeds from Issuance of Private Placement

Lite Strategy, Inc. (LITS) reported Proceeds from Issuance of Private Placement of $3.14 million for the 12-month period ending 2021-06-30, per its 10-K/A filed 2022-05-23.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2022-05-23

  • Lite Strategy, Inc. proceeds from issuance of private placement for fiscal 2021 was $3.14M, a 95.47% decline from fiscal 2020.
  • Lite Strategy, Inc. proceeds from issuance of private placement for fiscal 2020 was $69.23M, a 31368.64% increase from fiscal 2019.
  • Lite Strategy, Inc. proceeds from issuance of private placement for fiscal 2019 was $220.00K, a 99.69% decline from fiscal 2018.
  • Lite Strategy, Inc. proceeds from issuance of private placement for fiscal 2018 was $70.15M, a 1565.50% increase from fiscal 2017.
Period endProceeds from Issuance of Private Placement 1 monthProceeds from Issuance of Private Placement 12 month
2021-06-30$3.14M
10-K/A · filed 2022-05-23
2020-06-30$69.23M
10-K/A · filed 2022-05-23
2019-06-30$220.00K
10-K/A · filed 2022-05-23
2018-06-30$70.15M
10-K · filed 2020-09-09
2018-05-31$70.20M
10-Q · filed 2018-11-08
2017-06-30$4.21M
10-K · filed 2019-08-28
2006-07-31$16.80M
10-K · filed 2013-09-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Xilio Therapeutics, Inc. (XLO)United States$0.052B
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Clene Inc. (CLNN)United States$0.054B-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38